Stranahan Donald, Cherpelis Basil S, Glass L Frank, Ladd Sharron, Fenske Neil A
Department of Dermatology and Cutaneous Surgery, University of South Florida, Tampa, Florida, USA.
Dermatol Surg. 2009 Jul;35(7):1023-34. doi: 10.1111/j.1524-4725.2009.01179.x. Epub 2009 Apr 16.
During Mohs surgery, there are instances in which residual tumor cells may be difficult to detect, thereby increasing the risk of incomplete excision and tumor recurrence. It is possible to employ immunohistochemical techniques as an adjunct to routine hematoxylin and eosin staining to aid in ensuring negative margins.
To review the literature regarding the use of immunostains in Mohs surgery.
Various immunostains have proved useful in detecting tumor cells in various malignancies, including melanoma, basal cell carcinoma, squamous cell carcinoma, dermatofibrosarcoma protuberans, extramammary Paget's disease, primary cutaneous mucinous carcinoma, granular cell tumor, and trichilemmal carcinoma.
In this article, we review immunohistochemical stains that have been employed in Mohs micrographic surgery and evaluate their utility in enhancing detection of residual tumors with respect to tumor type, particularly in situations in which detection of residual tumor may be difficult.
在莫氏手术过程中,有时残留肿瘤细胞可能难以检测到,从而增加了切除不完全和肿瘤复发的风险。可以采用免疫组化技术作为常规苏木精和伊红染色的辅助手段,以帮助确保切缘阴性。
回顾关于免疫染色在莫氏手术中应用的文献。
各种免疫染色已被证明在检测各种恶性肿瘤中的肿瘤细胞方面有用,包括黑色素瘤、基底细胞癌、鳞状细胞癌、隆突性皮肤纤维肉瘤、乳腺外佩吉特病、原发性皮肤黏液癌、颗粒细胞瘤和毛母质瘤。
在本文中,我们回顾了在莫氏显微手术中使用的免疫组化染色,并评估了它们在增强对残留肿瘤的检测方面对于肿瘤类型的效用,特别是在残留肿瘤检测可能困难的情况下。